文献速递乳腺US乳腺X线MR

解读乳腺疾病标志物

Demystifying Breast Disease Markers.
PubMed 文献 · Radiographics · 2023-01-01

本文系统回顾乳腺常见良恶性疾病的组织病理学表型及免疫组化标志物,强调影像引导活检后放射-病理一致性评估对避免误诊和指导治疗的关键作用,并指出活检假阴性率受活检方式、针径和病灶类型等因素影响。

要点

  • 影像引导活检后需将影像表现与组织病理结果对照,评估放射-病理一致性以指导管理。
  • 活检假阴性率因活检方式(空心针、真空辅助针)、针径和病灶类型(肿块、钙化、不对称、结构扭曲)而异。
  • 熟悉乳腺大体与微观解剖及常见疾病的预期影像表现,有助提高放射-病理一致性判断的准确性。

核心结论

  • 放射科医生应掌握组织病理诊断基础及其对患者管理的影响,在多学科团队中确保恰当的放射-病理一致性,以优化患者照护。

研究设计与样本

  • 综述性文章,回顾乳腺常见良恶性疾病、其对应组织病理表型及确诊所需的组织病理标志物;未报告检索范围与纳入文献数量。

诊断标准与关键数值

  • 基于影像特征提示恶性可能性从2%至大于95%的病灶行影像引导活检(BI-RADS 4类和5类);苏木精-伊红染色提供形态学细节,免疫组化染色实现分子表征。

临床应用与阅片要点

  • 放射科医生作为多学科团队成员,应了解组织病理诊断基础及其对患者管理的意义,以确保恰当的放射-病理一致性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Breast imaging radiologists regularly perform image-guided biopsies of suspicious breast lesions based on features that are associated with a likelihood of malignancy ranging from 2% to greater than 95% (Breast Imaging Reporting and Data System categories 4 and 5). As diagnostic partners, pathologists perform histopathologic assessment of these tissue samples to confirm a diagnosis. Correlating the imaging findings with the histopathologic results is an integral aspect of multidisciplinary breast care. Assessment of radiologic-pathologic concordance is vital in guiding appropriate management, as it enables identification of discordant results, minimizing the chance of misdiagnosis. Undersampling can lead to false-negative results, with the frequencies of false-negative diagnoses varying on the basis of multiple factors, including biopsy type (eg, core needle, vacuum-assisted needle), needle gauge, and type of lesion sampled at biopsy (ie, mass, calcifications, asymmetry, architectural distortion). Improving a radiologist's knowledge of macroscopic and microscopic breast anatomy and more common breast diseases and their expected imaging findings ensures more accurate radiologic-pathologic correlation and management recommendations. The histopathologic and molecular characteristics of biopsy-sampled breast lesions aid in making an accurate diagnosis. Hematoxylin-eosin staining provides critical morphologic details, whereas immunohistochemical staining enables molecular characterization of many benign and malignant lesions, which is critical for tailored treatment. The authors review commonly encountered benign and malignant breast diseases, their corresponding histopathologic phenotypes, and the histopathologic markers that are essential to clinching the diagnosis of these entities. As part of a multidisciplinary team that provides optimal patient care, radiologists should be knowledgeable of the foundations of histopathologic diagnosis and the implications for patient management to ensure appropriate radiologic-pathologic concordance. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Wells VA, Medeiros I, Shevtsov A, et al. Demystifying Breast Disease Markers. Radiographics. 2023. PMID: 37676826. doi:10.1148/rg.220151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。